SCHEMBL734110

SCHEMBL734110

c1ccc2c(c1)CN(CCc1c[nH]c3ccccc13)C2

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.70
HTR1A P08908 4/20 0.69
HTR7 P34969 2/20 0.69
DRD2 P14416 2/20 0.69
DRD3 P35462 2/20 0.69
SLC6A4 P31645 1/20 0.69
HRH1 P35367 1/20 0.69
HDAC1 Q13547 1/20 0.58
HTR6 P50406 2/20 0.56
CYP2D6 P10635 2/20 0.55
BCHE P06276 1/20 0.55
MAPT P10636 2/20 0.55
RAB9A P51151 2/20 0.55
MEN1 O00255 1/20 0.55
NPC1 O15118 1/20 0.55
GAA P10253 1/20 0.55
KMT2A Q03164 1/20 0.55
MPO P05164 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734941 0.90 HTR2A (0.85) HTR2AHTR1AHTR7DRD2DRD3
SCHEMBL6465788 0.85 HTR2A (0.88) HTR2AHTR1ADRD2DRD3HTR6
SCHEMBL8872774 0.84 BCHE (0.73) HTR2AHTR1AHTR7DRD2DRD3
SCHEMBL735143 0.83 HTR2A (0.78) HTR2AHTR1ADRD2DRD3HTR6
SCHEMBL25295661 0.83 HTR2A (1.00) HTR2AHTR1ADRD2DRD3CYP2D6
SCHEMBL733629 0.83 HTR2A (0.94) HTR2AHTR1ADRD2DRD3CYP2D6
SCHEMBL29543272 0.83 HTR2A (0.94) HTR2AHTR1ADRD2DRD3CYP2D6
SCHEMBL20359039 0.82 HTR1A (1.00) HTR2AHTR1AHTR7DRD2DRD3
SCHEMBL32669458 0.81 HTR2A (0.91) HTR2AHTR1ADRD2DRD3CYP2D6
SCHEMBL734226 0.81 HTR2A (0.91) HTR2AHTR1ADRD2DRD3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101516844-B 4-heteroaryl substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having activity on opioid receptor systems GRUENENTHAL GMBH 2013-12-11 CN disclosed
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
CN-101516844-A 4-heteroaryl substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having activity on opioid receptor systems GRUENENTHAL GMBH (DE) 2009-08-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 HTR2A 238/4885HTR1A 746/4885HTR7 265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.